Oragenics Inc (OGEN) stock
OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.21+0.01 (+6.06%)
Close on Nov 17, 2026Market cap $947.51KP/E –Yield –
Oragenics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Oragenics's price to sales ratio was 461.1× on Oct 31, 2012, against 440.3× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2012 | Oct 31, 2012 | 461.1× | +328.7 |
| 2011 | Dec 30, 2011 | 132.3× | – |
See a number that looks wrong?